Noland Langford, CEO of Left Brain Capital Management, is betting on beaten down health care names by buying the bonds, not the stocks.

At a town hall meeting last night, presidential candidate Hillary Clinton vowed to "go after," Valeant Pharmaceuticals, after a woman handed her a note about her diabetes medication. The note said ...

Valeant's takeover bid for Allergan has been once again rejected by the company's board - which has used increasingly vivid language to dismiss the unwanted advances. Valeant and its 'activist ...

The FDA has finally approved Valeant’s eye drug Vyzulta after the company finally satisfied the regulator’s concerns over its manufacturing facility in Florida. The Quebec-based company’s ...

All at once, everyone wants to know more about the mysterious programs that Valeant Pharmaceuticals uses to help people buy its drugs - patient assistance programs. The programs were mentioned in ...

Bill Ackman, the billionaire founder of Pershing Square Capital, spent nearly four hours hosting a call defending his massive investment in Valeant Pharmaceuticals. Ackman has lost more than $1 ...

GSK will also gain the rights to Valeant's back-up compounds that target potassium channels. Valeant receives an upfront payment of $125 million, and will share up to 50% of net profits on ...

Canada-based Valeant Pharmaceuticals announced on August 20 that it had entered into a definitive agreement to buy Sprout Pharmaceuticals for $1bn, with the opportunity for Sprout to enjoy a share of ...

This advertisement has not loaded yet, but your article continues below. Here’s what investors will be keeping an eye on the week of August 7 to August 11 365 Bloor Street East, Toronto, Ontario ...